Skip to search formSkip to main contentSkip to account menu

CHOP protocol-cyclophosphamide/doxorubicin/prednisone/vincristine

Known as: CTX/DOX/PRED/VCR, ACOP, cyclophosphamide, doxorubicin, prednisone, and vincristine protocol 
National Institutes of Health

Related topics

Related topics

15 relations

Broader (5)

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamideCyclophosphamide/Doxorubicin/Etoposide/Prednisone/VincristineDoxorubicin

Narrower (3)

CAUP protocolCHOP-14 protocolCHOP-21 protocol
CDE protocol-cyclophosphamide/doxorubicin/etoposideCHOP regimenDoxorubicin HydrochloridePrednisone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
GLUT 12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK 2 signaling
Despite altered metabolism being an accepted hallmark of cancer, it is still not completely understood which signaling pathways… 
2014
2014
Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo.
BACKGROUND/AIM Lipitor is a cholesterol-lowering drug and Celebrex is a Cyclooxygenase-2 inhibitor. We investigated the effects… 
2009
2009
Molecular outcome prediction in diffuse large-B-cell lymphoma.
To the Editor: Lenz et al. (Nov. 27 issue)1 report the results of an important study of gene expression and survival in patients… 
2007
2007
Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides
Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for… 
2007
2007
THE ACOP FAMILY OF BEANS: A FRAMEWORK INDEPENDENT APPROACH
The current ACOP (Advanced Component Oriented Programming)* controls set has now been expanded to include a wide variety of… 
2006
2006
Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphoma
Long-term remission after autologous peripheral blood stem cell transplantation for relapsed intravascular lymphoma 
2005
2005
Initial phase II results of SGN-30 (anti-CD30 monoclonal antibody) in patients with refractory or recurrent systemic anaplastic large cell lymphoma (ALCL)
6601 Background: SGN-30 is a chimeric monoclonal antibody (mAb) directed against the CD30 antigen expressed on hematologic… 
Review
1997
Review
1997
The Use of ACOP Tools in Writing Control System Software
Several institutes are making increasing use of PCs in accelerator controls. In particular, Windows NT and/or Windows 95 is… 
1989
1989
[Peripheral T-cell lymphoma initially presenting as secondary myelofibrosis].
A case of peripheral T-cell lymphoma presenting with secondary myelofibrosis and meningeal involvement is described. A 65-year… 
1984
1984
A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.
In 1976 we began a randomized study for the treatment of patients with stage III and IV diffuse histiocytic lymphoma. The therapy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)